Home
Orbimed Advisors, 10% Owner: NeuroPace NPCE Sell · Filed 24/04/23
Trade details
- Type
- Insider sale
- Amount
- $345,756.45
- Shares · price
- 24,609 sh · $14.05 a share
- Held after
- 3,459,113 sh
- Stock
- NeuroPace NPCE
- Trade date
- 24/04/22
- Filed
- 24/04/23
- Days to filing
- 1 days
Sold 0.7% of holdings
- Share of holding sold
- 0.7%
NeuroPace trades, last 26 weeks
What else happened in NeuroPace around then
Filed or reported within 30 days of the trade day · 24/03/23~24/05/22Orbimed Advisors's recent trades
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
